Open AccessDexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells’ Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway
Author(s) -
Xianfeng Chen,
Juntao Hu,
Jie Lai,
Zhiyong Zhang,
Zhanhong Tang
Publication year - 2022
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2022/8433960
Subject(s) - downregulation and upregulation , inflammation , dexmedetomidine , agonist , microbiology and biotechnology , signal transduction , medicine , microrna , receptor , psychological repression , pharmacology , gene expression , immunology , biology , gene , biochemistry , sedation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom